市場調査レポート

商品コード

1741139

ドラッグ＆遺伝子デリバリーデバイス市場：製品別、市販薬別、地域別

Drug and Gene Delivery Devices Market, By Product, By Commercialized Drugs, and By Geography

出版日: 2025年03月26日
発行: Coherent Market Insights
ページ情報: 英文 155 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,500 648,360円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Multi User License)

USD 7,000 1,008,560円

レポートPDFを7名までにてご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は7回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise User License)

USD 10,000 1,440,800円

レポートPDFを同一企業およびその子会社のすべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.08円

全表示
概要
目次

概要

サンプル依頼リストに入れる

ドラッグ＆遺伝子デリバリーデバイス市場は、2025年には21万800米ドルと推定され、2032年には45万4,500米ドルに達すると予測され、2025～2032年のCAGRは11.6%で成長する見込みです。

レポート範囲		レポート詳細
基準年	2024年	2025年の市場規模	21万800米ドル
実績データ	2020～2024年	予測期間	2025～2032年
予測期間：2025～2032年のCAGR	11.60%	2032年の金額予測	45万4,500米ドル

ドラッグ＆遺伝子デリバリーデバイスのセグメントでは、細胞、組織、生体のタンパク質発現や機能を最終的に変化させる薬剤、遺伝子、遺伝子産物の開発と送達が行われます。ドラッグデリバリーデバイスは、特定の投与経路を通して薬剤を送達するために使用されるツールです。一方、遺伝子デリバリーは、DNAやRNAなどの外来遺伝物質を宿主細胞に導入するプロセスです。

市場力学

感染症、心血管疾患、がん、糖尿病などの慢性疾患の負担の増加、ドラッグ＆遺伝子デリバリーデバイスに対する需要の増加、細胞治療や遺伝子治療に対する資金提供の増加、遺伝子治療の承認の増加は、予測期間中に世界のドラッグ＆遺伝子デリバリーデバイス市場の成長を増大させると予想される主要因です。

例えば、2022年11月、Imunon, Inc.とAcuitas Therapeuticsは、IMUNONのPLACCINE核酸ワクチンコンストラクトとAcuitas独自の脂質デリバリー技術の組み合わせを評価する契約を締結しました。本契約に基づき、IMUNONはAcuitasの様々なLNP製剤に製剤化したベクタコンストラクトを投与し、マウスモデルにおける遺伝子発現と免疫原性を評価します。

この研究の主要特徴

本レポートは、世界のドラッグ＆遺伝子デリバリーデバイス機器市場を詳細に分析し、2024年を基準年とした予測期間2025～2032年の市場規模と複合年間成長率（CAGR%）を提供しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて、世界のドラッグ＆遺伝子デリバリーデバイス市場の主要企業をプロファイルしています。
本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
世界のドラッグ＆遺伝子デリバリーデバイス市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
利害関係者は、世界のドラッグ＆遺伝子デリバリーデバイス市場分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

Pfizer, Inc.
Novartis AG
Kite Pharma, Inc.
Bluebird bio, Inc.
Vericel Corporation
uniQure N.V.
Spark Therapeutics, Inc.
Renova Therapeutics
Orchard Therapeutics plc
Kolon Tissue Gene, Inc.
Human Stem Cell Institute
Amgen, Inc.
Dendreon Pharmaceuticals
Helixmith Co.
Bausch & Lomb Incorporated, Ltd.（ViroMed Co., Ltd.）
Becton Dickinson and Company
Castle Creek Biosciences, Inc.（Fibrocell Technologies, Inc.）

第9章セクション

調査手法
出版社について

Product Code: CMI5864

Drug and Gene Delivery Devices Market is estimated to be valued at USD 210.8 Thousand in 2025 and is expected to reach USD 454.5 Thousand by 2032, growing at a compound annual growth rate (CAGR) of 11.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 210.8 Thousand
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	11.60%	2032 Value Projection:	USD 454.5 Thousand

The field of drug and gene delivery involves the development and delivery of drugs, genes, and/or gene products that ultimately alter protein expression and function of the cells, tissues, and living organisms. Drug delivery devices are the tools used to deliver the drug through the specific route of administration. While, gene delivery is the process of introducing foreign genetic material, such as DNA or RNA, into host cells.

Market Dynamics:

Rise in burden of chronic diseases, such as infectious disease, cardiovascular disease, cancer, and diabetes, increasing demand for drug or gene delivery devices, increasing funding for cell and gene therapies, and rise in approvals for gene therapies are major factors expected to augment the growth of the global drug and gene delivery devices market over the forecast period.

For instance, in November 2022, Imunon, Inc. and Acuitas Therapeutics signed an agreement to evaluate the combination of IMUNON's PLACCINE nucleic acid vaccine constructs formulated with Acuitas' proprietary lipid delivery technology. Under the agreement, IMUNON will evaluate administration of its vector constructs formulated in various Acuitas LNP formulations for gene expression and immunogenicity in murine models.

Key features of the study:

This report provides in-depth analysis of the global drug and gene delivery devices market, and provides market size (US$ Thousand) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global drug and gene delivery devices market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Pfizer, Inc., Novartis AG, Kite Pharma, Inc., Bluebird bio, Inc., Becton, Amgen, Inc., Vericel Corporation, uniQure N.V., Spark Therapeutics, Inc., Renova Therapeutics, Orchard Therapeutics plc, Kolon Tissue Gene, Inc., Human Stem Cell Institute, Dendreon Pharmaceuticals, Dickinson and Company, Helixmith Co., Ltd (ViroMed Co., Ltd), Bausch & Lomb Incorporated, and Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.), among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global drug and gene delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug and gene delivery devices market.

Detailed Segmentation:

Global Drug and Gene Delivery Devices Market, By Product:
- Sub-retinal Injection Cannula
- Extension Tube
- Intravenous Catheter
- Sterile Insulin Syringe
- Pre-filled Syringe
- Infusion Bags
Global Drug and Gene Delivery Devices Market, By Commercialized Drugs:
- Luxturna (Drug Delivery Devices)
- Yescarta (Drug Delivery Devices)
- Zolgensma (Drug Delivery Devices)
- Kymriah (Drug Delivery Devices)
- Provenge (Drug Delivery Devices)
- Strimvelis (Drug Delivery Devices)
Global Drug and Gene Delivery Devices Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- Pfizer, Inc.
- Novartis AG
- Kite Pharma, Inc.
- Bluebird bio, Inc.
- Becton Dickinson and Company
- Amgen, Inc.
- Vericel Corporation
- uniQure N.V.
- Spark Therapeutics, Inc.
- Renova Therapeutics
- Orchard Therapeutics plc
- Kolon Tissue Gene, Inc.
- Human Stem Cell Institute
- Dendreon Pharmaceuticals
- Helixmith Co., Ltd (ViroMed Co., Ltd.)
- Bausch & Lomb Incorporated
- Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Commercialized Drugs
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Rise in burden of chronic diseases across the globe
- Stringent rules and regulations
- Increasing demand for drug and gene delivery devices
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Drug and Gene Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Drug and Gene Delivery Devices Market, By Product, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Sub-retinal Injection Cannula
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Extension Tube
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Intravenous Catheter
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Sterile Insulin Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Pre-filled Syringe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Infusion Bags
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)

6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Luxturna (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Yescarta (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Zolgensma (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Kymriah (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Provenge (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)
Strimvelis (Drug Delivery Devices)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Thousand)

7. Global Drug and Gene Delivery Devices Market, By Region, 2020-2032, (US$ Thousand)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Thousand)
- Market Size and Forecast, and Y-o-Y Growth, By Commercialized Drugs, 2020-2032,(US$ Thousand)

8. Competitive Landscape

Pfizer, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kite Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bluebird bio, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
uniQure N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Spark Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Renova Therapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Orchard Therapeutics plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Kolon Tissue Gene, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Human Stem Cell Institute
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Dendreon Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Helixmith Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bausch & Lomb Incorporated, Ltd. (ViroMed Co., Ltd.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton Dickinson and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Castle Creek Biosciences, Inc. (Fibrocell Technologies, Inc.)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

9. Section

Research Methodology
About us

ドラッグ＆遺伝子デリバリーデバイス市場：製品別、市販薬別、地域別

Drug and Gene Delivery Devices Market, By Product, By Commercialized Drugs, and By Geography

市場力学

この研究の主要特徴

目次

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界のドラッグ＆遺伝子デリバリーデバイス市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界のドラッグ＆遺伝子デリバリーデバイス市場、製品別、2020～2032年

第6章世界のドラッグ＆遺伝子デリバリーデバイス市場、市販薬別、2020～2032年

第7章世界のドラッグ＆遺伝子デリバリーデバイス市場、地域別、2020～2032年

第8章競合情勢

第9章セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Drug and Gene Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Drug and Gene Delivery Devices Market, By Product, 2020-2032, (US$ Thousand)

6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2020-2032, (US$ Thousand)

7. Global Drug and Gene Delivery Devices Market, By Region, 2020-2032, (US$ Thousand)

8. Competitive Landscape

9. Section

ドラッグ＆遺伝子デリバリーデバイス市場：製品別、市販薬別、地域別

Drug and Gene Delivery Devices Market, By Product, By Commercialized Drugs, and By Geography

市場力学

この研究の主要特徴

目次

第1章 調査の目的と前提条件

第2章 市場展望

第3章 市場力学、規制、動向分析

第4章 世界のドラッグ＆遺伝子デリバリーデバイス市場-コロナウイルス（COVID-19）パンデミックの影響

第5章 世界のドラッグ＆遺伝子デリバリーデバイス市場、製品別、2020～2032年

第6章 世界のドラッグ＆遺伝子デリバリーデバイス市場、市販薬別、2020～2032年

第7章 世界のドラッグ＆遺伝子デリバリーデバイス市場、地域別、2020～2032年

第8章 競合情勢

第9章 セクション

Market Dynamics:

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Drug and Gene Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Drug and Gene Delivery Devices Market, By Product, 2020-2032, (US$ Thousand)

6. Global Drug and Gene Delivery Devices Market, By Commercialized Drugs, 2020-2032, (US$ Thousand)

7. Global Drug and Gene Delivery Devices Market, By Region, 2020-2032, (US$ Thousand)

8. Competitive Landscape

9. Section

第1章調査の目的と前提条件

第2章市場展望

第3章市場力学、規制、動向分析

第4章世界のドラッグ＆遺伝子デリバリーデバイス市場-コロナウイルス（COVID-19）パンデミックの影響

第5章世界のドラッグ＆遺伝子デリバリーデバイス市場、製品別、2020～2032年

第6章世界のドラッグ＆遺伝子デリバリーデバイス市場、市販薬別、2020～2032年

第7章世界のドラッグ＆遺伝子デリバリーデバイス市場、地域別、2020～2032年

第8章競合情勢

第9章セクション